ACTSI Investigator Dr. Lawrence Phillips in the News

Lawrence Phillips, MD, ACTSI investigator, professor, Endocrinology Division, Emory University School of Medicine, and serves as medical director for the Clinical Studies Center at the Atlanta VA Medical Center. Diabetes is a public health problem of epidemic proportions in the U.S. and around the world. Dr. Phillips’ research is aimed to improve the early diagnosis and management of diabetes and pre-diabetes – to sustain beta cell function and improve the natural history of the disease. In his free time, Dr. Phillips has sung choral music for over 50 years, and met his wife (of 42 years!) through performing Beethoven’s Ninth Symphony with the Atlanta Symphony Orchestra and Chorus. 

Emory News Center| Diabetes researchers urge screening and management to benefit millions 
September 23, 2014
 
American Medical News | Programs deliver success for overweight, diabetic patients
July 8, 2013

Emory News Center | VA obesity study shows lifestyle change can work in a large health care system
June 25, 2013
 
Atlanta Business Chronicle | Diabetes trial
June 14, 2013

Atlanta Business Chronicle | Emory-VA collaborate on diabetes drug study
June 6, 2013

Atlanta Journal-Constitution | Anti-aging medicine earns converts and critics
September 24, 2012

Health News Digest | Type 2 Diabetes: Normal glucose levels should be the goal
August 1, 2012

Phillips is the principal investigator of a R21 grant from NIH entitled, Reach, Outcomes, and System Impacts of the VA’s National Weight Loss Program, MOVE. Phillips – Emory and the Atlanta VA Medical Center are participating in a new NIH study comparing the long-term benefits and risks of four widely used type 2 diabetes drugs in combination with the first-line drug metformin.
 
Publications: 
Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes. J Psychiatr Res 2014 May;52:21-7. Read more…

Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased diagnostic specificity. Diabet Med 2014 Apr 2. doi: 10.1111/dme.12459. [Epub ahead of print] Read more

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause 2014 Mar;21(3):260-6.Read more…

Predictors of Diabetes Mellitus and Abnormal Blood Glucose in Patients Receiving Opiod Maintenance Treatment. American Journal on Addictions 2013: 22(4); 411-416. Read more…Sex Hormone Levels and Risk of Breast Cancer With Estrogen Plus Progestin. J Natl Cancer Inst 2013; 105(19)1496-1503.Read more…
 
Screening for diabetes and prediabetes should be cost-saving in patients at high risk. Diabetes Care 2013: 36(7); 1981-1987. Read more… 

Science Advance: Emory-VA Collaborate on Diabetes Drug Study

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?